Status:
TERMINATED
Round Spermatid Injection Protocol
Lead Sponsor:
Reproductive Medicine Associates of New Jersey
Conditions:
Male Infertility Due to Azoospermia
Eligibility:
MALE
18+ years
Brief Summary
To evaluate embryology outcomes after application of a technique known as round spermatid injection (ROSI) into donor oocytes in a high-volume clinical infertility practice.
Detailed Description
The objective of this study is to assess embryology outcomes after implementation of a laboratory protocol known as ROSI at a high-volume clinical infertility practice. All samples from enrolled male ...
Eligibility Criteria
Inclusion
- Major Inclusion Criteria: The following are major inclusion criteria:
- A diagnosis of azoospermia after semen analysis.
- Indication to proceed with testicular sperm extraction (TESE or microTESE) based on a urologic evaluation.
- Presence of round spermatids from testicular sperm extraction (TESE or microTESE), irrespective of the presence or absence of mature spermatozoa.
- Major Exclusion Criteria (must not meet any): The following are exclusion criteria:
- Under 18 years old
- All patients who do not voluntarily give their written consent for participation.
- Men who do not wish to use their gametes (round spermatids) for fertilization of donor oocytes for research purposes.
Exclusion
Key Trial Info
Start Date :
August 16 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 8 2021
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04053309
Start Date
August 16 2019
End Date
January 8 2021
Last Update
May 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reproductive Medicine Assoicates of New Jersey
Basking Ridge, New Jersey, United States, 07920